HSK7653 in Chinese Patients with Impaired Glucose Tolerance

Clinical trial NCT04727580 · COMPLETED

Trial details

NCT number: NCT04727580
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Impaired Glucose Tolerance

Start date: 2021-03-29
Primary completion: 2022-06-12
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.